Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Roche Holding AG (OTCQX International Premier:RHHVF)

244.00
Delayed Data
As of 3:58pm ET
 +3.72 / +1.55%
Today’s Change
221.66
Today|||52-Week Range
276.80
+7.04%
Year-to-Date
Roche Reports Positive Data from Tecentriq Combination Study
6:52pm / Zacks.com - Paid Partner Content
Building a Circle of Competency
Dec 05 / GuruFocus News - Paid Partner Content
Foreign Stock Roundup: Bank of Montreal Q4 Earnings Decline, Rio Tinto Lowers '17 Cap...
9:30am / Zacks.com - Paid Partner Content
Mylan Up on FDA Approval & Amazon's Rumored Pharmacy Interest
Dec 04 / Zacks.com - Paid Partner Content
Puma (PBYI) Stock Up More than 200% This Year: Here's Why
Dec 08 / Zacks.com - Paid Partner Content
Cancer Space Update: Pfizer's Bavencio Fails in Phase III
Dec 01 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: FDA Nod for NVO's Ozempic, Second Indication for Lilly's Taltz
Dec 08 / Zacks.com - Paid Partner Content
AbbVie Stock Up More Than 30% So Far in 2H17: Here's Why
Nov 30 / Zacks.com - Paid Partner Content
Roche Reports Tecentriq/Avastin Lung Cancer Study Data
Dec 07 / Zacks.com - Paid Partner Content
Biogen Acquires Worldwide License for Alkermes' MS Candidate (revised)
Nov 29 / Zacks.com - Paid Partner Content
Clovis' sNDA for Rubraca Gets Priority Review in the U.S.
Dec 06 / Zacks.com - Paid Partner Content
Top Stock Reports for Estee Lauder, Broadcom & General Dynamics
Nov 28 / Zacks.com - Paid Partner Content
Roche's Avastin Gets Full FDA Approval for Brain Cancer
Dec 06 / Zacks.com - Paid Partner Content
Biogen Acquires Worldwide License for Alkermes' MS Candidate
Nov 28 / Zacks.com - Paid Partner Content
Janssen, AbbVie's Imbruvica Achieves PFS in Innovate Study
Dec 06 / GuruFocus News - Paid Partner Content
AstraZeneca Files for Label Expansion of Tagrisso in Japan
Nov 28 / Zacks.com - Paid Partner Content
AbbVie/J&J's Imbruvica Succeeds in Combo Study with Rituxan
Dec 06 / Zacks.com - Paid Partner Content